A distinct arrest and reduction in the proliferation was seen in methylated MGMT (GSC_CL1) compared with the nonmethylated MGMT (GSC_CL2) glioma cell type, as reported previously (Schaub et al, 2018). Here, MGMT is linked to central nervous system cancer.